Natera
-
Duquesne, the family office of Stanley Druckenmiller, has made Natera (NTRA) its top holding for eight consecutive quarters.
Duquesne, the family office of renowned investor Stanley Druckenmiller, has listed healthcare diagnostics company Natera (NASDAQ: NTRA) as its largest holding for eight consecutive quarters. Natera sp
-
Billionaire Stanley Druckenmiller made cancer-testing firm Natera (NTRA) his largest holding, increasing stake in Q2 to $864.9 million, accounting for 16.6% of his reported portfolio.
Druckenmiller's Duquesne Family Office's latest 13F filing, dated August 14, 2026, revealed Natera as his top pick, with an additional 122,700 shares bought in Q2. He views Natera's Signatera cancer-t
-
Natera (NTRA) stock surged after reporting "blowout" Q2 results, driven by strong Signatera cancer test volume
An analyst noted "blowout volume" for Natera's Signatera cancer-detecting blood test in the second quarter, which saw 34,000 tests performed.
-
Hedge fund manager Stanley Druckenmiller has allocated 18% of his $3.4 billion portfolio to the genetic testing company Natera.
According to the latest 13-F filing, legendary hedge fund manager Stanley Druckenmiller, through his family office, increased his stake in genetic testing company Natera (Nasdaq: NTRA), making it the
-
Duquesne, the family office of Stanley Druckenmiller, has made Natera (NTRA) its top holding for eight consecutive quarters.
Duquesne, the family office of renowned investor Stanley Druckenmiller, has listed healthcare diagnostics company Natera (NASDAQ: NTRA) as its largest holding for eight consecutive quarters. Natera sp
-
Billionaire Stanley Druckenmiller made cancer-testing firm Natera (NTRA) his largest holding, increasing stake in Q2 to $864.9 million, accounting for 16.6% of his reported portfolio.
Druckenmiller's Duquesne Family Office's latest 13F filing, dated August 14, 2026, revealed Natera as his top pick, with an additional 122,700 shares bought in Q2. He views Natera's Signatera cancer-t
-
Natera (NTRA) stock surged after reporting "blowout" Q2 results, driven by strong Signatera cancer test volume
An analyst noted "blowout volume" for Natera's Signatera cancer-detecting blood test in the second quarter, which saw 34,000 tests performed.
-
Hedge fund manager Stanley Druckenmiller has allocated 18% of his $3.4 billion portfolio to the genetic testing company Natera.
According to the latest 13-F filing, legendary hedge fund manager Stanley Druckenmiller, through his family office, increased his stake in genetic testing company Natera (Nasdaq: NTRA), making it the
- No data
Natera
24H Trending
-
1
Goldman Sachs' latest research report: Maintains its year-end 2027 gold price target of $5,400, but lowers its year-end 2026 forecast to $4,650, stating that Federal Reserve rate hikes will only slow short-term gains, and central bank gold purchases are the core driver.
-
2
U.S. Energy Secretary Chris Wright says another round of crude loans from the Strategic Petroleum Reserve is a “very real possibility” amid higher oil prices and steep futures backwardation.
-
3
Hong Kong Financial Secretary Christopher Hui: The government is studying expanding the scope of RMB usage, including promoting RMB payment for stamp duty on stock transactions and an RMB counter for Stock Connect Southbound Trading.
-
4
Fed rate hike to 3.75%-4.00% pushes 1-year Treasury yield to 4.45%, making crypto lending less attractive
-
5
HKMA: The total number of stored value facility accounts reached 90.38 million in Q2 2026, a quarter-on-quarter increase of 1.8%.
-
6
NVIDIA's optimistic outlook boosts tech stocks, Nasdaq futures rise 0.7%, South Korea's KOSPI leads Asian markets with a 2.7% gain.
-
7
Brent crude oil fell 2.0% intraday, nearing $97/barrel, Bitcoin rose 1.2% to $77,426, and gold increased by 0.5%.
-
8
JPMorgan Chase and Santander Lead Over £1 Billion Loan for Drax's Acquisition of Bluefield Solar
-
9
Bitcoin Spot and Futures Trading Platform Guide: Choosing Secure and Compliant Global Channels
-
10
Prudential Exits AlexForbes as Motsepe’s ARC Boosts Stake
Markets Today
Recommended Reading

